IL17A and Alzheimer disease: Th17 cells have been shown to infiltrate the skin lesions of AD, particularly during the acute phase of dermatitis [22], which suggested that IL-17 produced from Th17 cells decreases TJ function by inhibiting the synthesis of ZO-1, claudin-1, and claudin-4 proteins in AD.